CLAD yields 198.02% · ABBV yields 3.06%● Live data
📍 CLAD pulled ahead of the other in Year 1
Combined, CLAD + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CLAD + ABBV for your $10,000?
China Liaoning Dingxu Ecological Agriculture Development, Inc., through its subsidiaries, grows, produces, markets, and sells agriculture products in the People's Republic of China. The company offers fresh mushrooms, such as oyster, king oyster, shiitake, king trumpet, and button mushrooms; dried mushrooms, including eryngii, white, jade, and white king oyster mushrooms, as well as ganoderma mushrooms; and mushroom seeds. It sells its fresh and dried mushrooms to stores that sell directly to individual customers; and mushroom seeds to farmers in the form of stick shaped containers filled with fertilizers, as well as bottles of mushroom seeds. The company was formerly known as Hazlo! Technologies, Inc. and changed its name to China Liaoning Dingxu Ecological Agriculture Development, Inc. in October 2011. China Liaoning Dingxu Ecological Agriculture Development, Inc. was founded in 2009 and is based in West Palm Beach, Florida.
Full CLAD Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.